Recent advances in intra-articular drug delivery systems for osteoarthritis therapy

P Maudens, O Jordan, E Allémann - Drug discovery today, 2018 - Elsevier
Highlights•Precision medicine is necessary to treat multiple facets of osteoarthritis.•Disease-
modifying osteoarthritis drugs (DMOADs) and drug delivery systems (DDSs) are …

Cartilage-related collagens in osteoarthritis and rheumatoid arthritis: from pathogenesis to therapeutics

Z Ouyang, L Dong, F Yao, K Wang, Y Chen… - International Journal of …, 2023 - mdpi.com
Collagens serve essential mechanical functions throughout the body, particularly in the
connective tissues. In articular cartilage, collagens provide most of the biomechanical …

[HTML][HTML] Mesenchymal stromal/stem cell-derived extracellular vesicles promote human cartilage regeneration in vitro

LA Vonk, SFJ van Dooremalen, N Liv… - Theranostics, 2018 - ncbi.nlm.nih.gov
Osteoarthritis (OA) is a rheumatic disease leading to chronic pain and disability with no
effective treatment available. Recently, allogeneic human mesenchymal stromal/stem cells …

Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow‐up of three patients

F Davatchi, B Sadeghi Abdollahi… - … journal of rheumatic …, 2016 - Wiley Online Library
Aim Osteoarthritis is a degenerative joint disease characterized by the destruction of joint
cartilage. Mesenchymal stem cells (MSC s) are found in low numbers in normal cartilage …

Mesenchymal stem/stromal cells-derived extracellular vesicles as a potentially more beneficial therapeutic strategy than MSC-based treatment in a mild metabolic …

K Warmink, JL Rios, S Varderidou-Minasian… - Stem cell research & …, 2023 - Springer
Background Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular
vesicles (MSC-EVs) hold promise as a disease modifying treatment in osteoarthritis (OA) …

In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects

T Jiang, G Xu, Q Wang, L Yang, L Zheng, J Zhao… - Cell Death & …, 2017 - nature.com
In vitro cultured autologous mesenchymal stem cells (MSCs) within passage 5 have been
approved for clinical application in stem cell-based treatment of cartilage defects. However …

Tissue engineering strategies to study cartilage development, degeneration and regeneration

M Bhattacharjee, J Coburn, M Centola, S Murab… - Advanced drug delivery …, 2015 - Elsevier
Cartilage tissue engineering has primarily focused on the generation of grafts to repair
cartilage defects due to traumatic injury and disease. However engineered cartilage tissues …

[HTML][HTML] Thoughts on cartilage tissue engineering: A 21st century perspective

T Stampoultzis, P Karami, DP Pioletti - Current Research in Translational …, 2021 - Elsevier
In mature individuals, hyaline cartilage demonstrates a poor intrinsic capacity for repair, thus
even minor defects could result in progressive degeneration, impeding quality of life …

Hydrogel based cartilaginous tissue regeneration: recent insights and technologies

YJ Chuah, Y Peck, JEJ Lau, HT Hee, DA Wang - Biomaterials science, 2017 - pubs.rsc.org
Hydrogels have been extensively employed as an attractive biomaterial to address
numerous existing challenges in the fields of regenerative medicine and research because …

Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells

A Karystinou, AJ Roelofs, A Neve, FP Cantatore… - Arthritis research & …, 2015 - Springer
Introduction The control of differentiation of mesenchymal stromal/stem cells (MSCs) is
crucial for tissue engineering strategies employing MSCs. The purpose of this study was to …